Results 131 to 140 of about 737 (141)

Real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir in hospitalized patients with COVID‐19: A retrospective cohort study

Journal of Medical Virology, 2023
Guangtong Deng, Huiyan Sun, Yating Dian   +2 more
exaly  

Azvudine Reduce the In-Hospital Mortality of Patients with COVID-19 Pneumonia

2023
Kaican Zong, Hui Zhou, Wen Li, E Jiang, Yi Liu, Shiying Li   +5 more
openaire   +1 more source

Oral azvudine for mild‐to‐moderate COVID‐19 in high risk, nonhospitalized adults: Results of a real‐world study

Journal of Medical Virology, 2023
Chunguo Jiang, Xuefeng Liu, Zhaohui Tong   +2 more
exaly  

Real‐world effectiveness of Azvudine versus nirmatrelvir‐ritonavir in hospitalized patients with COVID‐19

Journal of Medical Virology, 2023
Guangting Zeng, Linlin Wang, Jianqiang Li, Zanling Zhang   +3 more
openaire   +2 more sources

Azvudine

Reactions Weekly
openaire   +2 more sources

A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

Advanced Science, 2020
Zhigang Ren, Zujiang Yu, Guangying Cui   +2 more
exaly  

Azvudine/ibrutinib

Reactions Weekly
openaire   +1 more source

Azvudine: a reverse transcriptase inhibitor for AIDS and COVID-19 treatment

Bin Yu, Junbiao Chang
openaire   +1 more source

Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort study

Journal of Infection
Mengzhao Yang, Guowu Qian, Silin Li
exaly  

Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world study

EClinicalMedicine
Miao Liu, Qiangguo Ao, Lining Xu
exaly